SI-BONE, Inc. SIBN
24.94 USD -0.16 (-0.64%)
At closeNov 11, 2026, 4:00 PM EST
24.94 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
24.73 Day range 25.47
11.48 52-week range 25.92
- YTD
- +26.47%
- 1 year
- +36.88%
News
seekingalpha.com SI-BONE, Inc. (SIBN) Presents at 2026 UBS Global Healthcare Conference Transcript SI-BONE, Inc. (SIBN) Presents at 2026 UBS Global Healthcare Conference Transcript
zacks.com SiBone (SIBN) Hit a 52 Week High, Can the Run Continue? Si-Bone (SIBN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
benzinga.com TD Cowen Maintains Buy on SI-BONE, Raises Price Target to $23 TD Cowen analyst Mathew Blackman maintains SI-BONE (NASDAQ:SIBN) with a Buy and raises the price target from $20 to $23.
benzinga.com Needham Maintains Buy on SI-BONE, Lowers Price Target to $26 Needham analyst David Saxon maintains SI-BONE (NASDAQ:SIBN) with a Buy and lowers the price target from $27 to $26.
benzinga.com SI-BONE Q3 2026 Earnings Call Transcript SI-BONE (NASDAQ:SIBN) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com SI-BONE Affirms FY2026 Sales Guidance of $231.000M-$233.000M vs $232.024M Est SI-BONE (NASDAQ:SIBN) affirms FY2026 sales outlook from $231.000 million-$233.000 million to $231.000 million-$233.000 million vs $232.024 million estimate.
benzinga.com SI-BONE Q3 EPS $(0.08) Beats $(0.13) Estimate, Sales $55.704M Beat $55.404M Estimate SI-BONE (NASDAQ:SIBN) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.13) by 33.33 percent. This is a 27.27 percent increase over losses of $(0.11) per…
benzinga.com Truist Securities Maintains Buy on SI-BONE, Raises Price Target to $25 Truist Securities analyst Richard Newitter maintains SI-BONE (NASDAQ:SIBN) with a Buy and raises the price target from $23 to $25.